{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T12:53:09Z","timestamp":1779022389811,"version":"3.51.4"},"reference-count":34,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2014,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>The Architect EBV antibody panel is a new chemiluminescence immunoassay system used to determine the stage of Epstein-Barr virus (EBV) infection based on the detection of IgM and IgG antibodies to viral capsid antigen (VCA) and IgG antibodies against Epstein-Barr nuclear antigen 1 (EBNA-1). We evaluated its diagnostic accuracy in immunocompetent adolescents and young adults with clinical suspicion of infectious mononucleosis (IM) using the RecomLine EBV IgM and IgG immunoblots as the reference standard. In addition, the use of the antibody panel in a sequential testing algorithm based on initial EBNA-1 IgG analysis was assessed for cost-effectiveness. Finally, we investigated the degree of cross-reactivity of the VCA IgM marker during other primary viral infections that may present with an EBV IM-like picture. High sensitivity (98.3% [95% confidence interval {CI}, 90.7 to 99.7%]) and specificity (94.2% [95% CI, 87.9 to 97.8%]) were found after testing 162 precharacterized archived serum samples. There was perfect agreement between the use of the antibody panel in sequential and parallel testing algorithms, but substantial cost savings (23%) were obtained with the sequential strategy. A high rate of reactive VCA IgM results was found in primary cytomegalovirus (CMV) infections (60.7%). In summary, the Architect EBV antibody panel performs satisfactorily in the investigation of EBV IM in immunocompetent adolescents and young adults, and the application of an EBNA-1 IgG-based sequential testing algorithm is cost-effective in this diagnostic setting. Concomitant testing for CMV is strongly recommended to aid in the interpretation of EBV serological patterns.<\/jats:p>","DOI":"10.1128\/cvi.00754-13","type":"journal-article","created":{"date-parts":[[2014,4,3]],"date-time":"2014-04-03T06:22:34Z","timestamp":1396506154000},"page":"817-823","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":31,"title":["Performance of the Architect EBV Antibody Panel for Determination of Epstein-Barr Virus Infection Stage in Immunocompetent Adolescents and Young Adults with Clinical Suspicion of Infectious Mononucleosis"],"prefix":"10.1128","volume":"21","author":[{"given":"Alvaro","family":"Guerrero-Ramos","sequence":"first","affiliation":[{"name":"Department of Virology, Royal Free London NHS Foundation Trust, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauli","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Virology, Royal Free London NHS Foundation Trust, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kinjal","family":"Kadakia","sequence":"additional","affiliation":[{"name":"Department of Virology, Royal Free London NHS Foundation Trust, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanzina","family":"Haque","sequence":"additional","affiliation":[{"name":"Department of Virology, Royal Free London NHS Foundation Trust, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"410","article-title":"Mononucleosis leukocytosis in reaction to acute infections (infectious mononucleosis)","volume":"31","author":"Sprunt TP","year":"1920","unstructured":"SpruntTPEvansFA. 1920. Mononucleosis leukocytosis in reaction to acute infections (infectious mononucleosis). Bull. Johns Hopkins Hosp. 31:410\u2013417.","journal-title":"Bull. Johns Hopkins Hosp."},{"key":"e_1_3_2_3_2","first-page":"182","article-title":"Infectious mononucleosis at the United States military academy. A prospective study of a single class over four years","volume":"47","author":"Hallee TJ","year":"1974","unstructured":"HalleeTJEvansASNiedermanJCBrooksCMVoegtlyH. 1974. Infectious mononucleosis at the United States military academy. A prospective study of a single class over four years. Yale J. Biol. Med. 47:182\u2013195.","journal-title":"Yale J. Biol. Med."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1001116"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2007.08.018"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.8.3381-3387.2004"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3109\/9781420014280","volume-title":"Epstein-Barr virus","author":"Tselis A","year":"2006","unstructured":"TselisAMerlineJRStorchGA. 2006. Epstein-Barr virus disease-serologic and virologic diagnosis, p 126\u2013146. In TselisAJensonHB (ed), Epstein-Barr virus, 1st ed. Taylor & Francis Group, New York, NY.","edition":"1"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.10.1.78-82.2003"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-0934(88)90060-2"},{"key":"e_1_3_2_10_2","first-page":"2655","volume-title":"Fields virology,","author":"Kieff E","year":"2007","unstructured":"KieffERickinsonAB. 2007. Epstein-Barr virus, p 2655\u20132700. In KnipeDMHowleyPMGriffinDELambRAMartinMARoizmanBStrausSE (ed), Fields virology, 5th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.","edition":"5"},{"key":"e_1_3_2_11_2","first-page":"223","article-title":"Simplicity through complexity: immunoblot with recombinant antigens as new gold standard in Epstein-Barr virus serology","volume":"47","author":"Bauer G","year":"2001","unstructured":"BauerG. 2001. Simplicity through complexity: immunoblot with recombinant antigens as new gold standard in Epstein-Barr virus serology. Clin. Lab. 47:223\u2013230.","journal-title":"Clin. Lab."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-0934(00)00301-3"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1089\/biores.2012.0274"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/B978-0-08-097037-0.00018-X","volume-title":"The immunoassay handbook","author":"Weeks I","year":"2013","unstructured":"WeeksIKrickaLJWildD. 2013. Signal generation and detection systems (excluding homogeneous assays), p 267\u2013285. In WildDJohnRSheehanCBinderSHeJ. (ed), The immunoassay handbook, 4th ed. Elsevier Ltd., Oxford, United Kingdom.","edition":"4"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12004"},{"key":"e_1_3_2_16_2","volume-title":"UK standards for microbiology investigations: Epstein-Barr virus serology","author":"Health Protection Agency","year":"2012","unstructured":"Health Protection Agency. 2012. UK standards for microbiology investigations: Epstein-Barr virus serology. Health Protection Agency, London, United Kingdom. http:\/\/www.hpa.org.uk\/webc\/HPAwebFile\/HPAweb_C\/1317131313375."},{"key":"e_1_3_2_17_2","article-title":"Epstein-Barr virus diagnostics: a challenge to test method and tester","author":"Bauer G","year":"2009","unstructured":"BauerG. 2009. Epstein-Barr virus diagnostics: a challenge to test method and tester. Current diagnostics in infectious and autoimmune diseases, p 1\u20135. 7th Mikrogen spring symposium.","journal-title":"Current diagnostics in infectious and autoimmune diseases, p 1\u20135. 7th Mikrogen spring symposium"},{"key":"e_1_3_2_18_2","first-page":"279","volume-title":"The Epstein-Barr virus","author":"Henle G","year":"1979","unstructured":"HenleGHenleW. 1979. The virus as the etiologic agent of infectious mononucleosis, p 279\u2013320. In EpsteinMAAchongBG (ed), The Epstein-Barr virus, 1st ed. Springer-Verlag, Berlin, Germany.","edition":"1"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1699-0463.1996.tb00737.x"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.2.570"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00372-09"},{"key":"e_1_3_2_22_2","first-page":"1339","article-title":"Evaluation of five enzyme immunoassays for detection of immunoglobulin M antibodies to Epstein-Barr virus viral capsid antigens","volume":"31","author":"Wiedbrauk DL","year":"1993","unstructured":"WiedbraukDLBassinS. 1993. Evaluation of five enzyme immunoassays for detection of immunoglobulin M antibodies to Epstein-Barr virus viral capsid antigens. J. Clin. Microbiol. 1993. 31:1339\u20131341.","journal-title":"J. Clin. Microbiol. 1993."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-0934(95)01971-5"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.10439"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-197811000-00010"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00486-10"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(199811)<186::AID-JMV2>3.0.CO;2-3"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/infdis\/121.6.608","article-title":"Infectious mononucleosis-like disease with negative heterophil agglutination test. Clinical features in relation to Epstein-Barr virus and cytomegalovirus antibodies","volume":"121","author":"Klemola E","year":"1970","unstructured":"KlemolaEVon EssenRHenleGHenleW. 1970. Infectious mononucleosis-like disease with negative heterophil agglutination test. Clinical features in relation to Epstein-Barr virus and cytomegalovirus antibodies. J. Infect. Dis. 121:608\u2013614.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199903253401217"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.45.1725"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.22109"},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/bmj.308.6928.595","article-title":"Human parvovirus B19. Hard to differentiate from infectious mononucleosis","volume":"308","author":"Jones JW","year":"1994","unstructured":"JonesJWPetherJVFrostRW. 1994. Human parvovirus B19. Hard to differentiate from infectious mononucleosis. BMJ 308:595.","journal-title":"BMJ"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00142-09"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00380-08"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.5501\/wjv.v1.i1.31"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00754-13","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00754-13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:50:30Z","timestamp":1627591830000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00754-13"}},"subtitle":[],"editor":[{"given":"V. M.","family":"Litwin","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["10.1128\/CVI.00754-13"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00754-13","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"2013-11-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-03-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-05-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}